Cancer
Mayo Clinic researchers used a new approach to chemotherapy to more than double the typical survival rate for patients with stomach cancer and peritoneal metastasis, which is cancer that has spread to the lining of the abdominal cavity.
Latest stories
Individualized Medicine
May 23, 2024
Clinical Trials
May 20, 2024
Clinical Trials
May 17, 2024
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community